Speech and Voice Response to a Levodopa Challenge in Late-Stage Parkinson’s Disease
BackgroundParkinson’s disease (PD) patients are affected by hypokinetic dysarthria, characterized by hypophonia and dysprosody, which worsens with disease progression. Levodopa’s (l-dopa) effect on quality of speech is inconclusive; no data are currently available for late-stage PD (LSPD).ObjectiveT...
Furkejuvvon:
| Váldodahkkit: | , , , , , , , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Frontiers Media S.A.
2017-08-01
|
| Ráidu: | Frontiers in Neurology |
| Fáttát: | |
| Liŋkkat: | http://journal.frontiersin.org/article/10.3389/fneur.2017.00432/full |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|
